SHILPAMED Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > shilpamed

Technical Analysis

Technical Strength: 7.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 60.1. According to RSI analysis, shilpamed is strong. 7.0 SHILPAMED RSI Chart
MACD (?) MACD: 21.3 and Signal Line: 12.2. According to MACD analysis, shilpamed is technically strong. 8.0 SHILPAMED MACD Chart
Simple Moving Average (?) According to simple moving average analysis, shilpamed is in a uptrend. Support level is at 655. 9.0 SHILPAMED Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, shilpamed is in a uptrend. Support level is at 628. 9.0 SHILPAMED Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.762. According to bollinger bands, shilpamed is technically strong. 7.0 SHILPAMED Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 646.0866 and 627.95. Resistance level is 704.8. 6.5 SHILPAMED Fibonacci Retracement Chart
Average True Range (?) ATR: 23.4 NA SHILPAMED Average True Range Chart
Average Directional Index (?) ADX is 29.8 which means SHILPAMED is in a trend. NA SHILPAMED Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 17, 2017
Open Price 659.5
High Price 663.9
Low Price 645.25
Close Price 656.85
Absolute Change -7.9
Percentage Change -1.19%
Weekly Change 1.78%
Monthly Change 12.4%
Yearly Change 15.6%
52-week high 786.9
52-week low 525.0
Corporate Actions
ExDate Purpose
March 21, 2017 INT DIV RE 0.60 PER SHARE
March 28, 2016 INT DIV-RE 0.60 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.762
Confidence in Beta8.23%
Market Capital Rs. 2532.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 14.38
TTM Price-to-Earnings (P/E) Ratio 45.7
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 17 October 2017: Deliverable Quantity:0 NA SHILPAMED Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 October 2017: Daily Volatility:0.5712 NA SHILPAMED Annualized Daily Volatility (Spot Price) Chart


October 09, 2017 SUpdatesShilpa Medicare Limited has informed the Exchange regarding 'This is to inform you that the US FDA has issued an Establishment Inspection Report (EIR) for the Company's generic pharmaceutical manufacturing facility at Jadcherla in Telangana, India which was inspected between 24th and 28th July 2017. The inspection has now been closed by the US FDA. The Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines in response to the form 483 issued at the end of inspection. The US FDA has reviewed the CAPA and has found them acceptable.'.
October 03, 2017 SShareholders meetingShilpa Medicare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2017
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 01, 2017 August 10, 2017 iResultsinter alia to consider the Un-audited Financial Results for the First Quarter ended 30th June, 2017 in compliance of Regulation 33 of the SEBI (LODR) Regulations, 2015.
May 18, 2017 May 29, 2017 IResultsInter alia to consider the Audited Financial Results for the quarter and financial year ended March 31, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 628.1 Rs. 636.7 Rs. 646.8 Rs. 655.3 Rs. 665.4 Rs. 674 Rs. 684.1